Calcium binding protein markers of GABA deficits in schizophrenia - Post mortem studies and animal models

Neurotoxicity Research

Volumn 6, Issue 1, 2004, Pages 57-61

  Reynolds, Gavin P ^a   Abdul Monim, Zuhal ^b   Neill, Joanna C ^b   Zhang, Zhi Jun ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Animal models; Calcium binding proteins; GABAergic neurons; Phencyclidine; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN;

ANIMAL; DISEASE MODEL; HUMAN; METABOLISM; PATHOLOGY; REVIEW; SCHIZOPHRENIA;

ANIMALS; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; SCHIZOPHRENIA;

EID: 3242809106     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033297     Document Type: Article

References (19)

1. Abdul-Monim Z, GP Reynolds and JC Neill (2003) The atypical antipsychotic ziprasidone, but not haloperidol, improves PCP-induced cognitive deficits in a serial reversal learning task in the rat. J. Psychopharm. 17, 57-65.
2. Akbarian S, JJ Kim, SG Potkin, JO Hagman, A Tafazzoli, WE Bunney Jr and EG Jones (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in pre-frontal cortex of schizophrenics. Arch. Gen. Psychiatry 52, 258-266.
3. Beasley CL and GP Reynolds (1997) Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr. Res. 24, 349-355.
4. Beasley CL, ZJ Zhang, I Patten and GP Reynolds (2002) Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium binding proteins. Biol. Psychiatry 52, 708-715.
5. Benes FM, J McSparren, ED Bird, JP SanGiovanni and SL Vincent (1991) Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 48, 996-1001.
6. Benes FM, EW Kwok, SL Vincent and MS Todtenkopf (1998) A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol. Psychiatry 44, 88-97.
7. Cochran SM, M Kennedy, CE McKerchar, LJ Steward, JA Pratt and BJ Morris (2003) Induction of metabolic hypofunction and neu-rochemical deficits after chronic intermittent exposure to phen-cyclidine: Differential modulation by antipsychotic drugs. Neuropsychopharmacology 28, 265-275.
8. Cotter D, S Landau, RL Stevenson, CL Beasley, G Chana, L MacMillan and IP Everall (2002) The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol. Psychiatry 51, 377-386.
9. Danos P, B Baumann, HG Bernstein, M Franz, R Stauch, G Northoff, D Krell, P Falkai and B Bogerts (1998) Schizophrenia and anteroventral thalamic nucleus: Selective decrease of parval-bumin-immunoreactive thalamocortical projection neurons. Psychiatry Res. - Neuroimaging 82, 1-10.
10. Javitt DC and SR Zukin (1991) Recent advances in the phencycli-dine model of schizophrenia. Am. J. Psychiatry 148, 1301-1308.
11. Jentsch JD, A Tran, D Le, KD Youngren and RH Roth (1997) Sub-chronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17, 92-99.
12. Olney JW and NB Farber (1995) Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52, 1015-1018.
13. Reynolds GP and CL Beasley (2001) GABAergic neuronal subtypes in the human frontal cortex - development and deficits in schizophrenia. J. Chem. Neuroanat. 22, 95-100.
14. Reynolds GP, ZJ Zhang and CL Beasley (2001) Neurochemical correlates of cortical GABAergic deficits in schizophrenia: Selective losses of calcium binding protein immunoreactivity. Brain Res. Bull. 55, 13-18.
15. Reynolds GP, CL Beasley and ZJ Zhang (2002) Understanding the neurotransmitter pathology of schizophrenia: Selective deficits of subtypes of cortical GABAergic neurons. J. Neural Transm. 109, 881-889.
16. Solbach S and MR Celio (1991) Ontogeny of the calcium binding protein parvalbumin in the rat nervous system. Anat. Embryol. 184, 103-124.
17. Todtenkopf MS and FW Benes (1998) Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and non-pyramidal neurons in hippocampus of schizophrenic brain. Synapse 29, 323-332.
18. Woo TU, RE Whitehead, DS Melchitzky and DA Lewis (1998) A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl. Acad. Sci. USA 95, 5341-5346.
19. Zhang ZJ and GP Reynolds (2002) A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr. Res. 55, 1-10.